RecruitingNCT06973824

A Twenty-years' Experience in Pituitary Disease.

A Twenty-years' Experience in Pituitary Disease: Identification of Prognostic Factors in Pituitary Tumors


Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment

1,600 participants

Start Date

Mar 10, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Pituitary tumors represent a heterogeneous group of neoplasms by histotype. The pituitary adenomas are the most frequent heteroformation, among those affecting the pituitary gland, followed by meningiomas, craniopharyngiomas, germosomes and tumours secondary, such as metastases and lymphomas. Since these conditions are considered rare, the data epidemiology and prognosis to predict the natural history of these diseases can not be considered conclusive. Pituitary adenomas are a useful model for epidemiology in the study of pathology pituitary. Over the past 20 years, several attempts have been made to identify unique prognostic factors, which predict the outcome of these pathologies, but without To arrive at a definitive classification. The purpose of this study aims to collect clinical, biochemical, morphological and pathological data on the retrospective and prospective cohort of over 1600 patients undergoing neurosurgical removal of pituitary tumors in the last 20 years, to develop a prognostic classification.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is reviewing 20 years of patient data from people who had surgery for pituitary tumors, to better understand long-term outcomes, treatment patterns, and how the disease affects patients over time. **You may be eligible if...** - You are 18 years or older - You had surgery for a pituitary tumor - You have a confirmed pathology (biopsy) diagnosis of a pituitary tumor - You have at least 2 years of follow-up medical records available **You may NOT be eligible if...** - You were under 18 at the time of diagnosis - You have less than 2 years of documented follow-up Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERFrequency of disease recurrence

To collect data of pituitary disease recurrence


Locations(1)

Fondazione Policlinico Gemelli IRCCS

Rome, IT, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06973824


Related Trials